Botox Treatment in Adductor Spasmodic Dysphonia: A Meta-Analysis

Boutsen, Frank; Cannito, Michael P.; Taylor, Merlin; Bender, Brenda
June 2002
Journal of Speech, Language & Hearing Research;Jun2002, Vol. 45 Issue 3, p469
Academic Journal
Over the years many studies have been conducted to document the treatment effects of Botulinum toxin type A in adductor spasmodic dysphonia. The results of these studies have led to the view that overall Botulinum toxin treatment is moderately effective. This study reviews efficacy research qualitatively and quantitatively to determine the extent to which this conclusion is fully supported by the data. Although the data indicate moderate overall improvement as a result of Botulinum toxin treatment, they also suggest significant variation across patients, measurements, and treatment conditions. This result, together with methodological limitations and lack of standardization in BT efficacy research, justifies caution when making inferences regarding BT treatment benefit in adductor spasmodic dysphonia.


Related Articles

  • Botox Smooths Voices.  // Current Health 2;Sep2004, Vol. 31 Issue 1, p7 

    Presents information on the use of Botox, a purified form of botulinum toxin A, against a voice disorder called spasmodic dysphonia.

  • Can Botox help ease psychogenic dysphonia? Epstein, Ruth // Pulse;10/13/2003, Vol. 63 Issue 41, p104 

    Presents question and answer on the significance of botulinum toxin in psychogenic dysphonia. Use of fibreopatic nasoendoscopy; Details of the laryngoscopic findings; Effects of injecting botulinum toxin on the condition.

  • Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphoniaG.GalardiR.GuerrieroS.AmadioL.Leocani... Galardi, G.; Guerriero, R.; Amadio, S.; Leocani, L.; Teggi, R.; Melloni, G.; Comi, G. // Neurological Sciences;Aug2001, Vol. 22 Issue 4, p303 

    Botulinum toxin (BT) injections into vocalis (thyroarytenoid) muscle is currently considered the first-choice treatment for adductor spasmodic dysphonia, producing improvement for an average period of 3 months. In our experience, sporadic failure of BT efficacy can occur even in patients usually...

  • Botulinum toxin A.  // Reactions Weekly;8/7/2010, Issue 1313, p12 

    The article describes the clinical cases of 11 patients who developed dysphonia or dysphagia following the administration of botulinum toxin A for airway compromise secondary to bilateral vocal fold motion impairment.

  • HISTOLOGY OF NERVES AND MUSCLES IN ADDUCTOR SPASMODIC DYSPHONIA. Chhetri, Dinesh K.; Vinters, Harry V.; Blumin, Joel H.; Berke, Gerald S. // Annals of Otology, Rhinology & Laryngology;Apr2003, Vol. 112 Issue 4, p334 

    To elucidate the etiology and pathophysiology of spasmodic dysphonia, we examined the adductor branch of the recurrent laryngeal nerve and the lateral cricoarytenoid muscle from 9 consecutive patients with this disorder who were previously treated with botulinum toxin. Histologic examination...

  • BOTULINUM TOXIN MANAGEMENT OF ADDUCTOR SPASMODIC DYSPHONIA AFTER FAILED RECURRENT LARYNGEAL NERVE SECTION. Sulica, Lucian; Brin, Mitchell F.; Blitzer, Andrew; Stewart, Celia F. // Annals of Otology, Rhinology & Laryngology;Jun2003, Vol. 112 Issue 6, p499 

    This study examined botulinum toxin type A (BTX-A) treatment of adductor spasmodic dysphonia patients who had previously undergone recurrent laryngeal nerve section that failed to control symptoms. Information was retrieved from records of patients treated by our group between 1984 and 1999....

  • Study: Botox Shots Restore Voices, Confidence to Voice Disorder Patients; Lasting Effects Seen in Three-Year Study of People With Spasmodic Dysphonia.  // Ascribe Newswire: Medicine;4/19/2004, p76 

    Botulinum toxin type A, known as Botox, has been used off-label for years to help people with spasmodic dysphonia, a rare and often-misdiagnosed voice disorder that makes the voice sound strained, broken or breathy. In the April issue of the journal "Archives of Otolaryngology, Head and Neck...

  • Selective Denervation: Reinnervation for the Control of Adductor Spasmodic Dysphonia. Allegretto, Michael; Morrison, Murray; Rummage, Linda; Lau, David P. // Journal of Otolaryngology;May/Jun2003, Vol. 32 Issue 3, p185 

    Objectives: The objective of this study was to evaluate the efficacy of a new surgical procedure for adductor spasmodic dysphonia (AddSD). This surgery involves the bilateral selective division of the adductor branches of the recurrent laryngeal nerves with immediate reinnervation of the distal...

  • Patient benefit from treatment with botulinum neurotoxin A for functional indications in otorhinolaryngology. Braun, Thomas; Gürkov, Robert; Hempel, John Martin; Berghaus, Alexander; Krause, Eike // European Archives of Oto-Rhino-Laryngology;Dec2010, Vol. 267 Issue 12, p1963 

    The objective of the study was to evaluate patient benefit and health-related quality of life after use of botulinum neurotoxin (BoNT) A for various otorhinolaryngological, functional (non-cosmetic) indications. The design consisted of a survey study of a patient cohort ( n = 40) treated with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics